Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „women“
Suchtreffer
Begriffe & Kennungen
Abiraterone Mylan · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Women who are
Eintrag öffnenAkeega · 4.3 · Women who are or may become pregnant (see section 4.6).
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.3 · Women of child-bearing potential who are not using reliable contraception (see sections 4.4 and 4.6).
Eintrag öffnenAptivus · 4.8 · Rash An interaction study in women between tipranavir, co-administered with low dose ritonavir, and ethinyl oe
Eintrag öffnenArava · 4.3 · • Breast-feeding women (see section 4.6).
Eintrag öffnenArava · 4.3 · • Breast-feeding women (see section 4.6).
Eintrag öffnenArava · 4.3 · • Breast-feeding women (see section 4.6).
Eintrag öffnenArava · 4.3 · • Pregnant women, or women of childbearing potential who are not using reliable contraception during treatment
Eintrag öffnenArava · 4.3 · • Pregnant women, or women of childbearing potential who are not using reliable contraception during treatment
Eintrag öffnenArava · 4.3 · • Pregnant women, or women of childbearing potential who are not using reliable contraception during treatment
Eintrag öffnenAubagio · 4.3 · Breast-feeding women (see section 4.6).
Eintrag öffnenAubagio · 4.3 · Pregnant women, or women of childbearing potential who are not using reliable contraception during treatment w
Eintrag öffnenAvastin · 4.8 · Congenital, familial, Cases of foetal abnormalities in women treated with bevacizumab and genetic disorder alo
Eintrag öffnenBemfola · 4.8 · Treatment in women
Eintrag öffnenBonviva · 4.5 · In healthy male volunteers and postmenopausal women, intravenous administration of ranitidine caused an increa
Eintrag öffnenBonviva · 4.8 · 6 Table 1: Adverse reactions occurring in postmenopausal women receiving Bonviva 150 mg once monthly or ibandr
Eintrag öffnenBonviva · 4.8 · In a two-year study in postmenopausal women with osteoporosis (BM 16549) the overall safety of Bonviva 150 mg
Eintrag öffnenBonviva · 4.8 · In the pivotal two-year study in postmenopausal women with osteoporosis (BM16550), the overall safety of intra
Eintrag öffnenBonviva · 4.8 · Table 1: Adverse reactions occurring in postmenopausal women receiving Bonviva 3 mg injection every 3 months o
Eintrag öffnenCellCept · 4.3 · • Treatment should not be given to women of childbearing potential who are not using highly effective contrace
Eintrag öffnen